Tue, Apr 23, 2024
Volume 8, Issue 1 (Winter 2022)
Caspian J Neurol Sci 2022, 8(1): 33-38 |
Back to browse issues page
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Besharati A, Saberi A, Ghorbani Shirkouhi S, Ashraf A, Hatamian H, Eslami Kenarsari H et al . Guillain-Barré Syndrome During the COVID-19 Pandemic and Pre-pandemic Periods. Caspian J Neurol Sci 2022; 8 (1) :33-38
URL: http://cjns.gums.ac.ir/article-1-496-en.html
URL: http://cjns.gums.ac.ir/article-1-496-en.html
Alyeh Besharati1 
, Alia Saberi2 
, Samaneh Ghorbani Shirkouhi3 , Ali Ashraf4 , Hamidreza Hatamian2 , Habib Eslami Kenarsari5 , Sasan Andalib * 6
, Alia Saberi2 , Samaneh Ghorbani Shirkouhi3 , Ali Ashraf4 , Hamidreza Hatamian2 , Habib Eslami Kenarsari5 , Sasan Andalib * 6
1- School of Medicine, Guilan University of Medical Sciences, Rasht, Iran.
2- Department of Neurology, Poursina Hospital, School of Medicine, Guilan University of Medical Sciences, Rasht, Iran.
3- School of Medicine, Shahroud University of Medical Sciences, Shahroud, Iran.
4- Department of Anesthesiology, School of Medicine, Guilan University of Medical Sciences, Rasht, Iran.
5- Vice-Chancellor for Research and Technology, Guilan University of Medical Sciences, Rasht, Iran.
6- Department of Clinical Research, Research Unit of Clinical Physiology and Nuclear Medicine, School of Health Sciences, University of Southern Denmark, Odense, Denmark. , andalib@health.sdu.dk
2- Department of Neurology, Poursina Hospital, School of Medicine, Guilan University of Medical Sciences, Rasht, Iran.
3- School of Medicine, Shahroud University of Medical Sciences, Shahroud, Iran.
4- Department of Anesthesiology, School of Medicine, Guilan University of Medical Sciences, Rasht, Iran.
5- Vice-Chancellor for Research and Technology, Guilan University of Medical Sciences, Rasht, Iran.
6- Department of Clinical Research, Research Unit of Clinical Physiology and Nuclear Medicine, School of Health Sciences, University of Southern Denmark, Odense, Denmark. , andalib@health.sdu.dk
Abstract: (1117 Views)
Background: Guillain-Barré Syndrome (GBS) is an autoimmune disease that may occur after infections. As Coronavirus Disease 2019 (COVID-19) may bring about GBS, it is important to assess the effect of the COVID-19 pandemic on this disease
Objectives: This study aimed to compare the distribution and characteristics of GBS during and before the COVID-19 pandemic in an academic referral hospital in the north of Iran.
Materials & Methods: This retrospective study assessed GBS distribution and characteristics during the COVID-19 pandemic period (from March 2020 to the end of February 2021) and before the pandemic (from March 2019 to the end of February 2020) on 5340 patients referred to the Neurology Ward of Poursina Hospital of Guilan Province, in Iran.
Results: There was no significant difference between GBS distribution during (0.03%) and before (0.04%) the COVID-19 pandemic (P=0.413). There were also no differences between the two periods regarding the gender (P=0.659) and age (P=0.417) of the patients. The most common subtype of GBS during the COVID-19 pandemic was Acute Motor and Sensory Axonal Neuropathy (AMSAN) (71.4%). In both periods, the most common type of treatment was intravenous administration of immune globulin. There was no significant difference between the two periods (P=0.838) regarding the patients’ treatment response.
Conclusion: The distribution of GBS, its subtypes, type of treatment, and response to treatment were not different between the two study periods.
Objectives: This study aimed to compare the distribution and characteristics of GBS during and before the COVID-19 pandemic in an academic referral hospital in the north of Iran.
Materials & Methods: This retrospective study assessed GBS distribution and characteristics during the COVID-19 pandemic period (from March 2020 to the end of February 2021) and before the pandemic (from March 2019 to the end of February 2020) on 5340 patients referred to the Neurology Ward of Poursina Hospital of Guilan Province, in Iran.
Results: There was no significant difference between GBS distribution during (0.03%) and before (0.04%) the COVID-19 pandemic (P=0.413). There were also no differences between the two periods regarding the gender (P=0.659) and age (P=0.417) of the patients. The most common subtype of GBS during the COVID-19 pandemic was Acute Motor and Sensory Axonal Neuropathy (AMSAN) (71.4%). In both periods, the most common type of treatment was intravenous administration of immune globulin. There was no significant difference between the two periods (P=0.838) regarding the patients’ treatment response.
Conclusion: The distribution of GBS, its subtypes, type of treatment, and response to treatment were not different between the two study periods.
Type of Study: Research |
Subject:
Special
Received: 2021/08/31 | Accepted: 2021/10/9 | Published: 2022/01/1
Received: 2021/08/31 | Accepted: 2021/10/9 | Published: 2022/01/1
Send email to the article author
| Rights and permissions | |
 | This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
Articles Copyright © The Author(s).
Owned by Guilan University of Medical Sciences.
Co-published by Negah Institute for Scientific Communication.
Contact Information
Caspian Journal of Neurological Sciences
Guilan University of Medical Sciences
University Tel : +9813 3333 0939
E-mail: cjnsgums@gmail.com, cjns@gums.ac.ir
Owned by Guilan University of Medical Sciences.
Co-published by Negah Institute for Scientific Communication.
Contact Information
Caspian Journal of Neurological Sciences
Guilan University of Medical Sciences
University Tel : +9813 3333 0939
E-mail: cjnsgums@gmail.com, cjns@gums.ac.ir
